Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Return on Invested Capital: 2018-2019

Historic Return on Invested Capital for Neurocrine Biosciences (NBIX) over the last 2 years, with Dec 2019 value amounting to 0.05%.

  • Neurocrine Biosciences' Return on Invested Capital fell 5.00% to 0.05% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.05%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of 0.05% for FY2019, which is 2.00% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Return on Invested Capital stood at 0.05% for FY2019, which was up 41.36% from 0.04% recorded in FY2018.
  • Neurocrine Biosciences' Return on Invested Capital's 5-year high stood at 0.05% during FY2019, with a 5-year trough of 0.04% in FY2018.
  • Over the past 2 years, Neurocrine Biosciences' median Return on Invested Capital value was 0.05% (recorded in 2019), while the average stood at 0.05%.
  • Data for Neurocrine Biosciences' Return on Invested Capital shows a peak YoY rose of 2bps (in 2019) over the last 5 years.
  • Yearly analysis of 2 years shows Neurocrine Biosciences' Return on Invested Capital stood at 0.04% in 2018, then increased by 2bps to 0.05% in 2019.